Key result
Network pharmacology and transcriptomics analysis revealed that 82 natural compounds with anti-doxorubicin-induced cardiotoxicity potency could be divided into four groups corresponding to ten mechanism of action clusters.
Why the study?
Doxorubicin-induced cardiotoxicity limits its clinical oncologic benefit, and the mechanisms of action underlying natural compounds with cardioprotective potency remain poorly understood.
Population
Transcriptomics datasets of doxorubicin-treated and untreated cardiomyocytes and 82 publicly reported natural compounds
Comparison
82 natural compounds with anti-DIC potency across enriched pathway clusters
Design
Integrated transcriptomics and reverse pharmacophore mapping-based network pharmacology study
Authors
Loading...
Hypothesis-generating for natural compounds against doxorubicin cardiotoxicity; leaves open prospective validation before clinical consideration.
This bioinformatics study identified potential mechanisms of action for 82 natural compounds against doxorubicin-induced cardiotoxicity, providing a computational framework for future drug discovery and combination strategies.
Fang et al. (2021) studied Doxorubicin-Induced Cardiotoxicity. Natural Compounds was evaluated on Mechanisms of Action (MoAs) underlying drug interactions. Network pharmacology and transcriptomics analysis revealed that 82 natural compounds with anti-doxorubicin-induced cardiotoxicity potency could be divided into four groups corresponding to ten mechanism of action clusters.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: